After 6 years of research and over 200 trial crops, we've stabilised 8 commercially viable strains on our 65-hectare Sunshine Coast farm. Our efforts have attracted major Aussie and NZ offtake partners, securing commitments for our full licensed capacity.
Your investment will help complete Stage 1 infrastructure, boost production, and make premium medicinal cannabis accessible to all Australians.
Product / Service Details
Cannabis - By the People, For the People.
The People’s Plant™ is a family-owned, licensed medicinal cannabis farm redefining the Australian industry. With a hybrid perpetual harvest model, we combine indoor, greenhouse, and outdoor growing to ensure year-round, high-quality, affordable, and sustainable production. Our 64-hectare site supports large-scale cultivation, backed by innovative, solventless extraction methods. We’re working to break down barriers in the medicinal cannabis industry, creating a more accessible, affordable, and community-driven alternative to big corporations.
Business Model
Summary
The People’s Plant is committed to offering consistent high-quality medicinal cannabis at competitive prices. Our ambition is to lead the industry through cutting-edge strain development gold-standard solventless extraction.
Description
Our Opti-Grow™ model is meticulously designed to maximise energy efficiency and minimise production costs, enabling us to achieve consistent high-quality yields at the most affordable prices, all while minimising our environmental impact.
We adhere to strict regulatory compliance with rigorous quality control and possess all necessary licenses. Our strong partnerships in logistics and distribution ensure we remain competitive and responsive. In Stage 1, we will supply our cannabis to our offtake partners while also laying the groundwork for international expansion and developing new products.
Mission & Objectives
Mission
The People's Plant aims to revolutionise the medicinal cannabis industry by setting a new standard for quality, efficacy, and sustainability, leveraging our proprietary Opti-Grow™ methodology and cutting-edge gold-standard solventless extraction.
Business Objectives
Our goal is to be Australia’s most trusted and loved producer of affordable, high-quality medicinal cannabis by entering the market competitively, gaining share quickly, and leading through innovation.
Our Opti-Grow™ method combines indoor and outdoor cultivation with solventless extraction to set a new industry standard. After six years of R&D, we’ve developed cost-effective techniques that deliver premium medicinal cannabis at lower prices, ensuring accessibility, sustainability, and quality for Australian patients.
Industry
Summary
The Australian medicinal cannabis market is anticipated to reach approximately AU$1.37 billion by 2030, growing at a Compound Annual Growth Rate of 33.6% from 2024 to 2030.
Description
In 2023, Australia saw a 69% rise in cannabis imports, while local production grew by just 7%. Globally, the market is set to expand from AU$100 billion in 2025 to AU$150 billion by 2030. As access improves, Australia is emerging as a global leader in cannabis consumption. Shifts in consumer preferences and regulatory changes suggest a growing acceptance of medicinal cannabis usage. Driving reform is underway in several states to reflect this change. Despite this growth, local cultivation remains limited, with very few permitted producers.
